Tatsuo Kurokawa,

President DIA
Japan Self-Medication Industry

Dr. Kurokawa started his career as a government official of the Ministry of Health and Welfare (later the Ministry of Health, Labour and Welfare) in Japan.  After seven years of experience in good manufacturing processes and drug safety/monitoring, he was dispatched to the World Health Organization, Geneva and Manila Office, as an associate expert. After returning to Japan in 1982, he worked in science and technology policy, and for the promotion of bilateral and multilateral international collaborations, including trade issues among industrialized countries.  

In 1989, Dr. Kurokawa was transferred to the New Drug Division where he was involved in anti-cancer drug evaluation; participated in launching the work of the International Council on Harmonisation with colleagues from the European Commission and the US; and served as a member of the International Council on Harmonisation Steering Committee up to ICH-3 (1995).  In 1994, he became Director, Office of Appropriate Use of Drug, which is responsible for drug safety, and he then became Director of the Food Chemical Division followed by an appointment as Director of Safety Division, Ministry of Health, Labour and Welfare.  In 2004, Dr. Kurokawa was appointed as Councilor, Minister’s Secretariat on Pharmaceutical Affairs, Ministry of Health, Labour and Welfare, and in 2008, he retired from this role at the Ministry of Health, Labour and Welfare and became a professor of international drug development and regulation, Faculty of Pharmaceutical and Medical Sciences at Keio University. In 2016, he retired from the university and became President of the Japan Self-Medication Industry.  Dr. Kurokawa is a pharmacist and earned his doctorate in 1995 at Chiba University, Faculty of Pharmaceutical Sciences.

Our Leadership